Delivery Order SPE2DB20D3101-SPE2DB23FRVY0

Award Date 8/28/23
Potential Completion Date 8/29/23
Potential Value $54K
Ultimate Awardee
Cencora, Inc.
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a delivery order valued at $3,992.38 for the supply of 2,400,000 units of Bicillin L-A, a 4 ml injectable medication. The contract was awarded by the Defense Logistics Agency (DLA), a defense agency, and has an ultimate completion date of September 28, 2022. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to...
This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a delivery order valued at $8,226.75 for the supply of 1,200,000 units of Bicillin L-A, a pharmaceutical product. The contract was awarded by the Defense Logistics Agency (DLA), a defense agency, and has a completion date of February 13, 2024. The contract is a firm fixed-price delivery order and does not have a set-aside designation, indicating it was awarded through full and open competition....
This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a delivery order (SPE2DB23FT9K2) valued at $1,072.54 for the supply of 1,200,000 units of Bicillin L-A, a penicillin medication, to the Defense Logistics Agency (DLA). The contract has an ultimate completion date of April 6, 2023 and is a firm fixed-price arrangement. Amerisourcebergen, a major pharmaceutical distributor, holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $1,072.54 firm fixed-price delivery order is for the supply of 1,200,000 units of Bicillin L-A, a prescription medication, to support military healthcare programs. The contract has an ultimate completion date of July 6, 2023. Amerisourcebergen Drug Corp, a major pharmaceutical distributor, holds a significant $999,999,999 Indefinite Delivery Contract...
This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a delivery order worth $2,150.36 for the supply of 1,200,000 units of Bicillin L-A, a prescription medication. The award was made by the Defense Logistics Agency (DLA), a defense agency, on March 8, 2023, with a completion date of March 9, 2023. The contract has a firm fixed price pricing type and does not have any set-aside designation, indicating open competition. Amerisourcebergen Drug Corp holds a...
This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a delivery order (SPE2DB22FL39E) valued at $161,714.88 for the supply of 1,200,000 units of Bicillin L-A, a pharmaceutical product. The award was made by the Defense Logistics Agency (DLA), a defense agency, on May 16, 2022, with a completion date of May 17, 2022. This contract does not have a set-aside designation, indicating it was competed openly. Amerisourcebergen Drug Corp holds a significant...
This federal contract award to Amerisourcebergen Drug Corp (a major pharmaceutical distributor) is for the delivery of 2,400,000 units of Bicillin L-A, a penicillin-based medication, valued at $2,397.97. The contract, awarded by the Defense Logistics Agency (DLA), is a delivery order with a firm fixed price and a completion date of November 30, 2022. The contract does not have a set-aside designation, indicating open competition. Amerisourcebergen holds a larger $999,999,999 Indefinite...
This federal contract award to Amerisourcebergen Drug Corp. is for the delivery of 1,200,000 units of Bicillin L-A, a penicillin-based antibiotic, valued at $2,350.50. The contract, issued by the Defense Logistics Agency (DLA), is a Firm Fixed Price Delivery Order with a period of performance through January 29, 2024. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for the company to provide a...
This federal contract award, valued at $1,118.21, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is for the delivery of 1,200,000 units of Bicillin L-A, a medication, with an ultimate completion date of April 28, 2023. This is a firm fixed-price delivery order contract with no set-aside designation, indicating open competition. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $2,696.40 firm-fixed-price delivery order is for the supply of 1,200,000 units of Bicillin L-A, a penicillin-based medication, to support military healthcare programs. The contract has a performance period ending on December 29, 2023. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
  • SPE2DB20D3101
    Indefinite Delivery Contract
  • SPE2DB20D3101-SPE2DB23FRVY0
    Delivery Order

This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a delivery order valued at $53,627.00 for the supply of Bicillin L-A, a penicillin-based medication, to the Defense Logistics Agency (DLA). The contract has an ultimate completion date of August 29, 2023 and was awarded on August 28, 2023. This is a firm fixed-price contract, and there is no set-aside designation. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00, which serves as the primary vehicle for the company to deliver a comprehensive range of pharmaceutical products and medical supplies to support military and veteran healthcare programs globally. The company also maintains a separate IDC with the Department of Justice Federal Bureau of Investigation, valued at up to $750,000, for similar medical products and prescription drugs.

Generated 2/27/25, 10:44 AM